The Effect of Berry Extract on Helicobacter Pylori Eradication
The Adjuvant Effect of Berry Extract on Triple Therapy for Helicobacter Pylori Eradication
1 other identifier
interventional
120
1 country
1
Brief Summary
Helicobacter pylori (HP) is the major risk factors of gastritis, gastric ulcers, duodenal ulcers, mucosa associated lymphoid tissue lymphoma and gastric cancer. Helicobacter pylori are found in 70-90% of the population in developing countries and in 25-50% of developed countries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 29, 2009
CompletedFirst Posted
Study publicly available on registry
January 11, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedJanuary 14, 2010
January 1, 2010
11 months
December 29, 2009
January 13, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Eradication rate
4 weeks after Eradication of Helicobacter pylori
Study Arms (2)
Berry
PLACEBO COMPARATORPlacebo
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients older than 18
You may not qualify if:
- Pregnancy or breastfeeding
- Previous eradication treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, 111, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shih-Yi Huang, Ph.D
Taipei Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 29, 2009
First Posted
January 11, 2010
Study Start
January 1, 2009
Primary Completion
December 1, 2009
Study Completion
June 1, 2010
Last Updated
January 14, 2010
Record last verified: 2010-01